A therapeutic administration strategy involving the cyclical, timed dosing of exogenous compounds, often hormones or hormone precursors, designed to mimic natural physiological fluctuations or to intentionally create periods of low exposure to enhance receptor sensitivity. This approach contrasts with constant dosing, aiming to prevent receptor downregulation and improve overall therapeutic responsiveness. It is a sophisticated method of managing drug exposure profiles.
Origin
This term is rooted in clinical pharmacology, specifically pharmacokinetics (what the body does to the drug), applied strategically to endocrine replacement therapy. Cycling is employed when continuous exposure leads to receptor desensitization or unwanted downstream metabolic effects.
Mechanism
The mechanism relies on exploiting the half-life and receptor dynamics of the administered substance. By instituting planned periods where serum concentrations fall below a certain threshold, the body’s natural receptor up-regulation mechanisms are permitted to restore sensitivity. This strategy ensures that when the compound is reintroduced, the target tissues respond maximally, thereby requiring lower overall doses to achieve the desired biological effect.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.